First International Conference of Liver Pathobiology: From Bench to Bedside

Authors List

Important: The program online is copyrighted to each author and should not be copied and pasted!
Author Abstracts
Laszczewska Maja The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
Abu Bakar Nur Dianah Exploring Aspirin's Role in Mitigating Liver Cancer Development: Insights from a NASH Mouse Model
Ajouaou Yousra Epigenetic regulation by UHRF1 in the aging liver
Algueró Nadal Ana NASH has a tumor-suppressive effect through Yap driven cell competition
Amaya LUJAMBIO Outcome of Targeting ATR in High Replication Stress Murine HCC
Arconzo Maria Hepatic specific ablation of PGC-1α drives fibrosis in MASH model
Arslanow Anita Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
Assen Frank Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Augustin Hellmut Mechanosensitive self-fueling vascular Wnt controls liver function
Barcena-Varela Marina Intermittent fasting promotes immune escape in hepatocellular carcinoma.
Bataller Ramon Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic Hepatitis
Baweja Sukriti Gut and Circulating Bacterial Vesicles and their Virulence Factors Increase with Severity of Autoimmune Hepatitis
Carrot Edible Exosomes Potentiates a Therapy for Hepatic Encephalopathy by Modulating Gut Microbiota and Reducing Ammonia levels
Behrmann Iris Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
Bihari Chhagan Gut and Circulating Bacterial Vesicles and their Virulence Factors Increase with Severity of Autoimmune Hepatitis
Carrot Edible Exosomes Potentiates a Therapy for Hepatic Encephalopathy by Modulating Gut Microbiota and Reducing Ammonia levels
Bissig Karl-Dimiter Correcting metabolic liver disease by gene therapy
Brzozwoska Natalia Somatic mutations in steatotic liver disease lead to hepatic metabolic remodelling
Bujko Ania Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
Calderaro Julien Deep Learning-Based Phenotyping Reclassifies Combined Hepatocellular-Cholangiocarcinoma
Califano Andrea Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
Cameron Rainie The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
Campbell Peter Somatic mutations in steatotic liver disease lead to hepatic metabolic remodelling
Carlessi Rodrigo Novel pre-malignant hepatocyte state (daHep) accumulates in liver disease and predicts HCC risk
Caruso Stefano Deep Learning-Based Phenotyping Reclassifies Combined Hepatocellular-Cholangiocarcinoma
Casado Marta Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic target
Casper Markus Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
Céline POPHILLAT Outcome of Targeting ATR in High Replication Stress Murine HCC
Chantal DESDOUETS Outcome of Targeting ATR in High Replication Stress Murine HCC
Chen Zhen Injury-induced hepatocyte dedifferentiation in liver regeneration and tumorigenesis
Macrophage mediated senescent cell elimination in a liver cancer model in zebrafish
Christelle KABORE Outcome of Targeting ATR in High Replication Stress Murine HCC
Collins Amy The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
Cordier Pierre Polyploidy, DNA damage response driver or gatekeeper of chronic liver diseases
Cucarella Carme Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic target
Dalgarno Kenny The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
De Ponti Federico Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
Delpierre Julien Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
Desdouets Chantal Polyploidy, DNA damage response driver or gatekeeper of chronic liver diseases
Donne Romain Intermittent fasting promotes immune escape in hepatocellular carcinoma.
Dooley Steven Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
Dowbaj Anna Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
Duncan Stephen Understanding the Role of HNF1B in the Transition of the Endoderm to a Hepatic Fate
Dwyer Benjamin Development of a precision bio-printed liver tumour patient-derived organoid platform
Ebert Matthias Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
Fan Weiguo Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
Fernandez Mercedes Translational control in liver disease
Filliol Aveline Regulation of hepatocyte functions by hepatic stellate cells in health and disease
Fuertes-Agudo Marina Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic target
Gaigneaux Anthoula Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
Geh Daniel The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
Ghaffari Laleh Narmin Deep Learning-Based Phenotyping Reclassifies Combined Hepatocellular-Cholangiocarcinoma
Go Shirley Development of a precision bio-printed liver tumour patient-derived organoid platform
Halder Georg NASH has a tumor-suppressive effect through Yap driven cell competition
In Vivo Tracking and 3D Mapping of Cell Death during Liver Regeneration and Cancer
Hatzigeogriou Artemis Pathway analysis including miRNA function.
He Shirui Identifying drivers of liver cancer using CRISPR activation screening in vivo
Heikenwälder Mathias, Characterization of a novel Er stress inducing oncoprotein that restricts immunosurveillance
Henderson Neil Multimodal decoding of human liver regeneration
Ho Yu-jui Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
Hoek Jan Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic Hepatitis
Hofer Benedikt Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Holmes Alan` Disease-specific human ECM composition and bioactivity in NASH liver fibrosis
Huch Meritxell Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
Hui Lijian Injury-induced hepatocyte dedifferentiation in liver regeneration and tumorigenesis
Hylemon Phillip Dysregulated sphingolipid metabolism in MASH-HCC
Inverso Donato Vascular Control of Liver Pathobiology
Jean-Pierre COUTY Outcome of Targeting ATR in High Replication Stress Murine HCC
Jessica ZUCMAN-ROSSI Outcome of Targeting ATR in High Replication Stress Murine HCC
Jing FANG Outcome of Targeting ATR in High Replication Stress Murine HCC
Joana ARAUJO Outcome of Targeting ATR in High Replication Stress Murine HCC
Kain Renate Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Kaltenecker Christopher Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Kardaras Filippos Pathway analysis including miRNA function.
Karpale Mikko The distinct effects of oxygen shortage, Roxadustat and HIF-P4H-2 inhibition on mouse embryonic fibroblasts and hepatic stellate cell activation
Kather Jakob Deep Learning-Based Phenotyping Reclassifies Combined Hepatocellular-Cholangiocarcinoma
Kirchmeyer Mélanie Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
Koche Richard Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
Koivunen Peppi The distinct effects of oxygen shortage, Roxadustat and HIF-P4H-2 inhibition on mouse embryonic fibroblasts and hepatic stellate cell activation
Kondylis Vangelis A Mavs-dependent type I IFN pathway contributes to non-viral liver injury upon hepatic autophagy impairment
Königshofer Philipp Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Krawczyk Marcin Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
Kuehn Ariane Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
Lammert Frank Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
Landerer Cedric Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
Leclercq Isabelle the niche map of ductular reaction-driven regeneration
Lee Markcus Identifying drivers of liver cancer using CRISPR activation screening in vivo
Mechanosensitive self-fueling vascular Wnt controls liver function
Leedman Peter Development of a precision bio-printed liver tumour patient-derived organoid platform
Leslie Jack The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
Li Yujia Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
Liebling Ian Intermittent fasting promotes immune escape in hepatocellular carcinoma.
Lindblad Kathrenine Intermittent fasting promotes immune escape in hepatocellular carcinoma.
Link Frederik Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
Long PAN Outcome of Targeting ATR in High Replication Stress Murine HCC
Longato Lisa Disease-specific human ECM composition and bioactivity in NASH liver fibrosis
Lowe Scott Targeting senescence mechanisms in liver fibrosis and cancer
Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
Lozano Anthony Intermittent fasting promotes immune escape in hepatocellular carcinoma.
Luedde Tom How programmed cell death and cell death responses control HCC development
Lujambio Amaia Notch1 promotes sexually dimorphic immune responses in HCC
Intermittent fasting promotes immune escape in hepatocellular carcinoma.
Luque-Tévar María Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic target
Macchi Filippo Epigenetic regulation by UHRF1 in the aging liver
Macrophage mediated senescent cell elimination in a liver cancer model in zebrafish
Magnani Elena Macrophage mediated senescent cell elimination in a liver cancer model in zebrafish
Mahadevan Radhakrishnan Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic Hepatitis
Manchel Alexandra Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic Hepatitis
Manco Rita the niche map of ductular reaction-driven regeneration
Mandorfer Matthias Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Mann Derek The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
Martens Liesbet Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
Martín-Sanz Paloma Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic target
Martinez-Morant Carla Understanding the Role of HNF1B in the Transition of the Endoderm to a Hepatic Fate
Matchett Kylie Multimodal decoding of human liver regeneration
Matrella Maria Laura Hepatic specific ablation of PGC-1α drives fibrosis in MASH model
McBain Ian Macrophage mediated senescent cell elimination in a liver cancer model in zebrafish
Merens Vincent Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
Miliotis Marios Pathway analysis including miRNA function.
Mol Hasse NASH has a tumor-suppressive effect through Yap driven cell competition
Moschetta Antonio Hepatic specific ablation of PGC-1α drives fibrosis in MASH model
Moschopoulou Athina Development and characterization of kinase sparing TPX2-tethering Aurora Kinase A ligands for cancer therapy
Moya Ivan In Vivo Tracking and 3D Mapping of Cell Death during Liver Regeneration and Cancer
Mozayani Behrang Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Munker Stefan Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
Murali Rajmohan Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
Nair Ajay Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
Neirynck Gauthier the niche map of ductular reaction-driven regeneration
Nelson Glyn The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
Niksic Armin Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
Nwosu Zeribe Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
Oakley Fiona The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
Pajvani Utpal Maladaptive re-activation of morphogenic signaling in liver as causal to NASH-induced fibrosis
Parmentier Fleur Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
Pasic Sara Development of a precision bio-printed liver tumour patient-derived organoid platform
Pasparakis Manolis A Mavs-dependent type I IFN pathway contributes to non-viral liver injury upon hepatic autophagy impairment
Peiseler Moritz Visualizing Kupffer cell adaptations in liver fibrosis
Petrenko Oleksandr Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Piccinin Elena Hepatic specific ablation of PGC-1α drives fibrosis in MASH model
Qiyuan HE Outcome of Targeting ATR in High Replication Stress Murine HCC
Ramon-Gil Erik The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
Reeves Helen The development of ex vivo models of hepatocellular carcinoma for therapeutic screening and as a precision medicine tool.
Reiberger Thomas Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Romain DONNE Outcome of Targeting ATR in High Replication Stress Murine HCC
ruf Benjamin Deciphering Mucosal-Associated Invariant T (MAIT) Cell Regulation Networks in Liver Cancer
Sadler Kirsten Epigenetic regulation of liver development, cancer & regeneration
Macrophage mediated senescent cell elimination in a liver cancer model in zebrafish
Sadler Edepli Kirsten Epigenetic regulation by UHRF1 in the aging liver
Saito Yoshinobu Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
Salgado Alexandra Vazquez Novel mechanisms regulating cancer risk revealed by CRISPR screening in vivo
Sarin Shiv Gut and Circulating Bacterial Vesicles and their Virulence Factors Increase with Severity of Autoimmune Hepatitis
Carrot Edible Exosomes Potentiates a Therapy for Hepatic Encephalopathy by Modulating Gut Microbiota and Reducing Ammonia levels
Schneider Anne How programmed cell death and cell death responses control HCC development
A Mavs-dependent type I IFN pathway contributes to non-viral liver injury upon hepatic autophagy impairment
Schwabe Robert Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
Regulation of hepatocyte functions by hepatic stellate cells in health and disease
Schwabl Philipp Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Scott Charlotte Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
Semmler Georg Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Sen Payel Epigenetic mechanisms of tissue aging
Servais Florence Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
Séverine MORIZUR Outcome of Targeting ATR in High Replication Stress Murine HCC
Shirolkar Gayatri Development of a precision bio-printed liver tumour patient-derived organoid platform
Siermala Sofia The distinct effects of oxygen shortage, Roxadustat and HIF-P4H-2 inhibition on mouse embryonic fibroblasts and hepatic stellate cell activation
Simbrunner Benedikt Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Skoufos Giorgos Pathway analysis including miRNA function.
Sljukic Aleksandra Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
Sorz Thomas Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Steffani Marcella Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
Subudhi P Debishree Carrot Edible Exosomes Potentiates a Therapy for Hepatic Encephalopathy by Modulating Gut Microbiota and Reducing Ammonia levels
Sun Qiuyan Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
CELL-TRANSPLANTATION-INDUCED REPROGRAMMING STATE IS ESSENTIAL FOR HEPATOCYTE ENGRAFTMENT
Talianidis Iannis The oncogenic function of Smyd3 histone methyltransferase in liver and colon cancer
Tapiola Atte The distinct effects of oxygen shortage, Roxadustat and HIF-P4H-2 inhibition on mouse embryonic fibroblasts and hepatic stellate cell activation
Taru Vlad Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Tastsoglou Spyros Pathway analysis including miRNA function.
Tchorz Jan Game of zones: WNTer is coming
Thangariyal Swati Gut and Circulating Bacterial Vesicles and their Virulence Factors Increase with Severity of Autoimmune Hepatitis
Thone Tinne Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
Tibballs Jonathan Development of a precision bio-printed liver tumour patient-derived organoid platform
Tirnitz-Parker Janina Development of a precision bio-printed liver tumour patient-derived organoid platform
Novel pre-malignant hepatocyte state (daHep) accumulates in liver disease and predicts HCC risk
Trauner Michael Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Tsanov Kaloyan Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
Vadigepalli Rajanikanth Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic Hepatitis
van Grunsven Leo Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
Vanneste Bavo Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
Vázquez Salgado Alexandra Identifying drivers of liver cancer using CRISPR activation screening in vivo
Verhulst Stefaan Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
Villani Gaetano Hepatic specific ablation of PGC-1α drives fibrosis in MASH model
Vujkovic Marijana Multiancestry genome-wide studies in nonalcoholic fatty liver disease studies
Wallace Michael Development of a precision bio-printed liver tumour patient-derived organoid platform
Waller Kathryn Efferocytosis regulates phenotypes of resident and recruited macrophages in distinct models of hepatic injury.
Wang Sai Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
Dysregulated sphingolipid metabolism in MASH-HCC
Epigenetic regulation by UHRF1 in the aging liver
Wangensteen Kirk Identifying drivers of liver cancer using CRISPR activation screening in vivo
Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
Novel mechanisms regulating cancer risk revealed by CRISPR screening in vivo
Way Rachel Development of a precision bio-printed liver tumour patient-derived organoid platform
Weng Honglei Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
Weninger Wolfgang Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Willenbring Holger Approaches to extending the reach of liver gene therapy
Winteringham Louise Development of a precision bio-printed liver tumour patient-derived organoid platform
Yin Dingzi Novel mechanisms regulating cancer risk revealed by CRISPR screening in vivo
Zender Lars Development and characterization of kinase sparing TPX2-tethering Aurora Kinase A ligands for cancer therapy
Zeng Qinghe Deep Learning-Based Phenotyping Reclassifies Combined Hepatocellular-Cholangiocarcinoma
Dysregulated sphingolipid metabolism in MASH-HCC
Zerial Marino Multicellular liver organoids recapitulate homeostatic and fibrotic peri-portal liver tissue architecture and cellular interactions in vitro.
Zhao Derrick Dysregulated sphingolipid metabolism in MASH-HCC
Zhou Huiping Dysregulated sphingolipid metabolism in MASH-HCC
Zhu Changyu Diet-induced steatosis is a driver of liver metastasis from pancreatic cancer
Zinober Kerstin Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Zoppolato Elena NASH has a tumor-suppressive effect through Yap driven cell competition
Zucman-Rossi Jessica Genetic predisposition to liver cancer